KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways

Abstract

Abstract:The signaling cascades of the mitogen activated protein kinase (MAPK) family, calcineurin/NFATc4, and PI3K/Akt/GSK3, are believed to participate in endothelin-1 (ET-1)-induced cardiac hypertrophy. The aim of this study was to investigate whether KMUP-1, a synthetic xanthine-based derivative, prevents cardiomyocyte hypertrophy induced by ET-1 and to elucidate the underlying mechanisms. We found that in H9c2 cardiomyocytes, stimulation with ET-1 (100 nM) for 4 days induced cell hypertrophy and enhanced expressions of hypertrophic markers, including atrial natriuretic peptide and brain natriuretic peptide, which were all inhibited by KMUP-1 in a dose-dependent manner. In addition, KMUP-1 prevented ET-1-induced intracellular reactive oxygen species generation determined by the DCFH-DA assay in cardiomyocytes. KMUP-1 also attenuated phosphorylation of ERK1/2 and Akt/GSK-3β, and activation of calcineurin/NFATc4 and RhoA/ROCK pathways induced by ET-1. Furthermore, we found that the expression of heme oxygenase-1 (HO-1), a stress-response enzyme implicated in cardio-protection, was OPEN ACCESSMolecules 2015, 20 10436 up-regulated by KMUP-1. Finally, KMUP-1 attenuated ET-1-stimulated activator protein-1 DNA binding activity. In conclusion, KMUP-1 attenuates cardiomyocyte hypertrophy induced by ET-1 through inhibiting ERK1/2, calcineurin/NFATc4 and RhoA/ROCK pathways, with associated cardioprotective effects via HO-1 activation. Therefore, KMUP-1 may have a role in pharmacological therapy of cardiac hypertrophy.

The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats

“…IP3 can increase [Ca 2+ ] i and DAG can activate protein kinase C (PKC). Increased Ca 2+ and activation of PKC can lead to the early upregulation of proto-oncogenes, such as c-fos, c-myc, c-jun, and Egr-1; these genes encode proteins that act as third messengers that regulate the expression of target genes, which results in cardiac hypertrophy [ 20 ]. At the same time, Ang II could upregulate L-type-calcium channels, increasing calcium influx [ 21 ].…”

MicroRNA‐101b attenuates cardiomyocyte hypertrophy by inhibiting protein kinase C epsilon signaling

“…PKCε‐specific chemical inhibitor have been reported to block heart failure , suggesting that PKCε plays a pivotal role in cardiac hypertrophy and heart failure. A recent study has shown that the hypertrophic effects of PKCε in the heart are associated with the activation of the AKT and ERK pathways , and suppression of AKT can attenuate the progress of cardiac hypertrophy . Consequently, activated AKT suppresses GSK3β, the negative regulator of cardiac hypertrophy, and activates NFAT transcriptional factor by dephosphorylation (see Fig.…”

Apelin‑13 promotes cell proliferation in the H9c2 cardiomyoblast cell line by triggering extracellular signal‑regulated kinase 1/2 and protein kinase B phosphorylation

“…The signaling cascades of the mitogen activated protein kinase (MAPK) family, and phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt), are believed to be involved in cell-cycle regulation, apoptosis and inflammation (10,11). A growing body of evidence suggests that the Akt and extracellular signal-regulated (ERK) signaling pathway serve important roles in the development of cardiac hypertrophy and progression to HF.…”